Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) reported its third-quarter 2021 earnings today after the closing bell.
The revenue increased by 13% to $7.4 billion compared to the previous year.
The net income was $2.5 billion or $2.05 per share compared to $360 million or $0.29 per share of the same quarter in the previous year.
The adjusted earnings per share were $2.65 compared to $2.11 of the previous year.
S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…
Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…
Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…
CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…
Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…
The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…